
("Iofina", the "Company" or the "Group")
(AIM: IOF)
Q3 2025 Corporate Update
In the Period, Iofina Resources produced 215.8 metric tonnes ('MT') of crystalline iodide from its eight IOsorb® plants in Central and
Pricing and demand for raw iodine have remained strong. The average realised iodine spot price is steadily above
The negotiations with our IO#12 partner have entered the final stages, and we are hopeful of signing an agreement shortly, and expect to commence the plant's foundation work by the end of the year.
![]() |
President and CEO, Dr.
"The Company continues to execute its growth strategy as illustrated by the record month of September and Q3 2025 production increasing by 32% year on year. Importantly, production has been steady across all our plants, putting us on track for a crystalline iodine production range of 400-440 MT for the second half of the year, and ultimately, further full-year growth.
"With production at IO#11 commencing in July, the Company has met its target of building one new plant each year over the past three years. With negotiations for IO#12 now in the later stages, we expect to continue the delivery of a new plant for the fourth year running.
"With iodine prices remaining high and demand for Iofina's products only getting stronger, the Board is excited by the current outlook for the rest of the year and into 2026."
Enquiries:
Dr.
CEO & President
Tel: +44 (0)20 3006 3135
Nomad & Broker:
Tel: +44 (0)20 7523 8000
Financial PR and Media Contact:
Tel: +44 (0)7747 788 221/+44 (0)7983 521 488
About Iofina:
LEI: 213800QDMFYVRJYYTQ84
ISIN: GB00B2QL5C79
Iofina Resources
Iofina Resources develops, builds, owns, and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina operates eight IOsorb® plants in
Iofina Chemical
Iofina Chemical has manufactured high-quality halogen speciality chemicals derived from raw iodine, as well as non-iodine-based products. Iofina Chemical celebrated its 40th anniversary in 2023 as a preeminent halogen-based specialty chemicals company.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the